Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

Cystinosis is a rare genetic disorder characterized by the accumulation of cystine crystals in different tissues and organs causing, among other symptoms, severe ocular manifestations. Cysteamine eye drops are prepared in hospital pharmacy departments to facilitate access to treatment, for which veh...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ana Castro-Balado, Enrique Bandín-Vilar, Andrea Cuartero-Martínez, Laura García-Quintanilla, Gonzalo Hermelo-Vidal, Xurxo García-Otero, Lorena Rodríguez-Martínez, Jesús Mateos, Manuela Hernández-Blanco, Pablo Aguiar, Irene Zarra-Ferro, Miguel González-Barcia, Cristina Mondelo-García, Francisco J. Otero-Espinar, Anxo Fernández-Ferreiro
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-10-01
Col·lecció:	Pharmaceutics
Matèries:	cystinosis ophthalmic administration cysteamine compounded formulation PET
Accés en línia:	https://www.mdpi.com/1999-4923/14/10/2194
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!